LAUREN EMRICK: Open Payments
NPI 1306300249 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 25 payments from 11 companies in 2025. Trend: 2023 $365 · 2024 $470 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $175 |
| ABBVIE INC. | 2 | $55 |
| Exact Sciences Corporation | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Lilly USA, LLC | 2 | $43 |
| Amgen Inc. | 2 | $37 |
| SHIELD THERAPEUTICS INC | 1 | $25 |
| Corcept Therapeutics | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Wegovy, Ozempic, Cologuard Collection Kit, AIRSUPRA, MOUNJARO, UBRELVY, QULIPTA, ACCRUFER.
Industry payments across FL — which companies pay providers there.
